Pharmacological modulation of ghrelin signaling (e.g., AG antagonists or ghrelin receptor blockers) could help mitigate insulin resistance and hyperglycemia, particularly in individuals with low Akkermansia levels. This evidence concerns the gene RENBP and Hyperglycemia.